Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14651 - 14675 of 15249 in total
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
Investigational
Matched Description: … of Prolarix™ in Hepatocellular Carcinoma). ... Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety …
Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
Investigational
Matched Description: … , to Block Ethanol Effects in Humans). ... Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil …
Leridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
Investigational
Matched Description: … in Treating Older Patients With Acute Myeloid Leukemia). ... Leridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim …
Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).
Investigational
Matched Description: … in Subjects With Moderately Severe Asthma). ... Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 …
Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris).
Investigational
Matched Description: … in Patients With Pemphigus Vulgaris). ... Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 …
PXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults.
Investigational
Matched Description: … PXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults …
Plozasiran is under investigation in clinical trial NCT05089084 (Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)).
Investigational
Matched Description: … Plozasiran is under investigation in clinical trial NCT05089084 (Study of ARO-APOC3 (Plozasiran) in Adults …
N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. This medication is known to target n-acetylornithine carbamoyltransferase and putative ornithine carbamoyltransferase.
Experimental
Matched Description: … N-(3-carboxypropanoyl)-L-norvaline is a solid. …
Investigational
Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).
Investigational
Investigational
PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Iupac: … -{2-[(4aR,6S,8aR)-2-amino-6-methyl-4H,4aH,5H,6H,8H,8aH-pyrano[3,4-d][1,3]thiazin-8a-yl]-1,3-thiazol-4- …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …
Investigational
N-chlorotaurine is an inhibitor of inducible nitric oxide synthase and IkappaB kinase.
Investigational
Experimental
Matched Iupac: … (2S)-2-({[(S)-(2-imino-1,3-diazinan-4-yl)({[(1S)-3-methyl-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]carbamoyl …
Experimental
Vet approved
Matched Iupac: … 4-carbamoyl-1-{[(6R,7R)-2-carboxylato-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0] …
Experimental
Matched Iupac: … (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo …
Experimental
Matched Iupac: … (1R,2S,8S,10S,11S,13R,14R,15S,17S)-4-chloro-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15 …
Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.).
Investigational
Matched Iupac: … dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl}piperidin-4- …
Matched Description: … Simvastatin in Subjects With Primary Dyslipidemia.). ... Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and …
Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).
Investigational
Matched Description: … Verdinexor (Verdinexor) in Healthy Adults). ... Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral …
Menaquinone 7 is under investigation in clinical trial NCT00402974 (The Effect of Vitamin K Supplementation on Osteocalcin Carboxylation in Healthy Children).
Investigational
Matched Description: … on Osteocalcin Carboxylation in Healthy Children). ... Menaquinone 7 is under investigation in clinical trial NCT00402974 (The Effect of Vitamin K Supplementation …
Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease).
Investigational
Matched Description: … ® in Subjects With Early Alzheimer's Disease). ... Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen …
Pemvidutide is under investigation in clinical trial NCT05989711 (Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial)).
Investigational
Matched Description: … in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial)). ... Pemvidutide is under investigation in clinical trial NCT05989711 (Efficacy and Safety of Pemvidutide …
Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.
Investigational
Matched Description: … -2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in
Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.
Investigational
Matched Iupac: … )-2-{[(2S)-1-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4- …
Displaying drugs 14651 - 14675 of 15249 in total